Español
Keywords:
EspañolAbstract
On analyse the Spanish pharmaceutical market offer to cover the,. gastroesofagic reflux disease (GERD) therapy in paediatric population. A review of the pharmaceutical specialities corresponding to the groups A03AF, A02BA, and A02BC from the Specialities Catalogue of the Pharmaceutical College General Council attending to: Paediatric dosage and Pharmaceutical form this drugs are presento In the 44 % drugs in volved in GERD therapy specific paediatric studies aren't fit for use. The 33% of AH2 and 40% of IBP are usable in children. Any IBP has a correctly design presentation for paediatric population. On conclude that actual market hasn't correctly design medicines of the more effective therapies in the GERD treatment.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).